Biotech entity
All 1 tracked stories fall under one category: clinical-trial. University of Oxford is most often covered alongside Africa CDC, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention University of Oxford, all published on July 11, 2026.
Last mentioned: Jul 11, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: clinical-trial. University of Oxford is most often covered alongside Africa CDC, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention University of Oxford, all published on July 11, 2026. Each carries 7 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University of Oxford. Shared-story counts are live from our verified record — not editorial picks.
With no approved therapies for the Bundibugyo Ebola strain and an outbreak surpassing 500 fatalities, two candidate drugs have begun a clinical trial, and a prophylactic agent trial is imminent. The collaborative effort signals a pivot toward rapid, integrated R&D for neglected filoviruses.
University of Oxford is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
